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Novelty Statement 
• 71% of episodes of self-reported severe hypoglycaemia involved ambulance call out. 
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• Only 13% of all diabetes clinic consultations were documented as hypoglycaemia 
follow-up and at least 50% of people included in this study had no documented 
healthcare professional-recommended changes to diabetes treatment.  
• The results of our study suggest a lack of a consistent mechanism for reporting by 
paramedics to primary care and subsequent referral to specialist diabetes services, a 
lack of a consistent approach to early follow-up by specialist diabetes services, and 
low levels of healthcare professional-recommended therapy change and ongoing 
specialist review following self-reported episodes of severe hypoglycaemia. 
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Abstract 
Aims. To evaluate the impact of severe hypoglycaemia on NHS resources and overall 
glycaemic control in adults with Type 1 diabetes. 
Methods. An observational, retrospective study of adults (aged ≥18 years) with Type 1 
diabetes reporting one or more episodes of severe hypoglycaemia during the preceding 24 
months in 10 NHS hospital diabetes centres in England and Wales. The primary outcome 
was healthcare resource utilisation associated with severe hypoglycaemia. Secondary 
outcomes included demographic and clinical characteristics, diabetes control and pathway 
of care.  
Results. 140 episodes of severe hypoglycaemia were reported by 85 participants during the 
2-year observation period. Ambulances were called in 99/140 (71%) episodes, Accident and 
Emergency attendance occurred in 26/140 (19%) episodes, whereas 29/140 (21%) required 
no immediate help from healthcare providers. Participants attended a median of 5 (range: 
0–58) diabetes clinic consultations during the observation period; 13% (70/552) of all 
consultations were severe hypoglycaemia-related. Of the HbA1c measurements recorded 
closest prior to severe hypoglycaemia (n=119), only 7/119 measurements were <48 
mmol/mol (<6.5%) and mean HbA1c was 70 (SD: 19) mmol/mol (8.5% [SD: 1.7%]). 119 
changes to diabetes treatment were recorded during the observation period 
(median/person 0 [range: 0–11]), of which 52/119 changes (44%) followed severe 
hypoglycaemic events. 
Conclusions. We observed a high level of ambulance service intervention but surprisingly 
low levels of hypoglycaemia follow-up, therapy change and specialist intervention in people 
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self-reporting severe hypoglycaemia. These results suggest there may be important gaps in 
care pathways for people with Type 1 diabetes self-reporting severe hypoglycaemia. 
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Introduction 
Persistent hyperglycaemia in Type 1 diabetes is associated with microvascular complications 
and an increased risk of cardiovascular disease [1]. The Diabetes Control and Complications 
Trial (DCCT) demonstrated that intensive glycaemic control significantly reduced the 
incidence of microvascular and cardiovascular disease and slowed progression of 
microvascular complications [1–3]. However, intensive glycaemic control is associated with 
an increased risk of severe hypoglycaemia, defined as an event requiring the assistance of 
another person to treat [1,4]. 
Severe hypoglycaemia is associated with an increased risk of cardiovascular events [5], a 
reduction in quality of life, increased fear and anxiety, reduced productivity, and increased 
healthcare costs [4]. Fear of hypoglycaemia can lead to complex compensatory behaviour 
resulting in sub-optimal glycaemic control and an increased risk of developing chronic 
complications [4,6]. Modern Type 1 diabetes management emphasises structured 
education, for example through the DAFNE (Dose Adjustment for Normal Eating) 
programme [7], to enable people to tailor insulin dosing according to carbohydrate intake 
and exercise [4,8]. Despite such developments, severe hypoglycaemia remains a major 
hazard for people with Type 1 diabetes and is the most common diabetes emergency 
requiring ambulance service call-out and Accident and Emergency (A&E) attendance [9,10]. 
Although studies have reported resource utilisation associated with severe hypoglycaemia 
requiring ambulance attendance [5,9,11–14], there is limited real-world evidence reporting 
secondary care resource utilisation and  clinical intervention specifically associated with 
episodes of self-reported severe hypoglycaemia in people with Type 1 diabetes.  
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The objective of this study was to evaluate the impact of self-reported episodes of severe 
hypoglycaemia on secondary care resource use and diabetes management in people with 
Type 1 diabetes in a real-world setting, in order to understand current unmet need.  
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Methods 
Study design and setting 
We conducted an observational, multi-centre, retrospective study of people with Type 1 
diabetes in 10 NHS secondary care diabetes centres in England and Wales. Adults (>18 years 
of age) with Type 1 diabetes currently under the care of participating centres who had been 
treated with insulin for ≥2 years and who had experienced ≥1self-reported episode of 
severe hypoglycaemia in the previous 24 months were eligible for the study.  
Participants 
Eligible individuals were identified by members of the study team through a review of 
recent diabetes clinic lists, medical records and local databases and selected in reverse 
chronological order. Participants gave written informed consent for data collection from 
medical records according to a protocol approved by the NHS Research Ethics Service 
(reference 15/NI/0169). Data were collected between November 2015 and April 2016. 
Sample size 
As a retrospective descriptive study with a single cohort of participants, no formal power 
calculation was carried out. A target sample size of 50-80 was chosen to provide a 
representative sample of people with self-reported episodes of severe hypoglycaemia and 
provide adequate reliability for the study endpoints. 
Variables and outcomes 
The primary outcome of the study was a summary of the secondary healthcare resource 
utilisation associated with management of people with Type 1 diabetes self-reporting 
≥1episodes of severe hypoglycaemia. Healthcare resource utilisation included all diabetes 
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clinic consultations, planned and unplanned inpatient admissions, and other points of care 
in the diabetes pathway, including ambulance call-outs and Accident and Emergency (A&E) 
attendances during a 2-year period prior to data collection (observation period). Secondary 
outcomes included a summary of the profile of individuals reporting severe hypoglycaemia, 
their overall glycaemic control and pathway of care. Participant demographic and clinical 
characteristics (data as recorded closest to the time of data collection) included age, sex, 
duration of diabetes, body mass index (BMI), HbA1c, insulin therapy, comorbidities and 
concomitant medication. Glycaemic control and pathway of care included all documented 
episodes of severe hypoglycaemia, HbA1c measurements and insulin therapy changes 
recorded during the 2-year observation period. Post-hoc exploratory outcomes included: 
level of HbA1c measured closest prior to severe hypoglycaemia; time between episodes of 
severe hypoglycaemia and hypoglycaemia follow-up consultations; temporal relationship 
between episodes of severe hypoglycaemia, diabetes clinic consultations and changes to 
diabetes treatment. 
Statistical analyses 
Data were analysed with descriptive statistics, using only the available data; denominators 
are presented for all analyses where data were missing. Quantitative variables are 
presented as median (interquartile range [IQR] and/or range) or arithmetic mean (standard 
deviation [SD]). Categorical variables are presented as frequency (%). 
Costs associated with hospital resource utilisation were calculated using NHS reference 
costs 2014/2015 [15]. 
Sub-group analysis 
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In order to examine the temporal relationship between episodes of severe hypoglycaemia, 
diabetes clinic consultations and changes to diabetes treatment, we evaluated a sub-group 
of 72 severe hypoglycaemic episodes (in 63 participants) with 3 months’ data available both 
before (pre-hypo) and after the event (post-hypo).   
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RESULTS 
Baseline participant demographic and clinical characteristics 
Eighty-five participants from 10 hospitals in England and Wales were studied. Demographic 
and clinical characteristics are shown in Fig. 1 and Table 1. The mean age at data collection 
was 57.0 (SD: 14.8) years, 59% (n=50) of participants were men, and the mean duration of 
diabetes was 33.1 (SD: 14.2) years. At least one comorbidity was recorded for 78 (92%) 
participants (mean of 3.9 comorbidities [SD: 2.9] per person); none had Addison’s disease 
and only one had coeliac disease. The majority were using analogue and/or human 
sequence insulins, either in a multiple daily injection regimen (MDI) or as a continuous 
subcutaneous insulin infusion (CSII). 
 
Severe hypoglycaemic events and glycaemic control during the 2-year observation period 
A total of 140 episodes of severe hypoglycaemia were recorded during the 2-year 
observation period (median episodes per person 1 [range: 1–4]); 35/85 (41%) participants 
experienced more than one episode (Fig. 2). The majority of episodes required the 
assistance of a paramedic (106/140 episodes [76%]). Family members provided assistance 
for 15% (21/140) of episodes. 
A mean of 4.3 (SD: 1.9) HbA1c measurements per person (range: 1–10) were recorded during 
the 2-year observation period; 11/85 participants (13%) had at least one HbA1c 
concentration of ≤48 mmol/mol (≤6.5%) and 39/85 participants (46%) had at least one 
HbA1c concentration of ≤58 mmol/mol (≤7.5%) recorded at some point during the 2-year 
observation period. For the HbA1c recorded most closely prior to episodes of severe 
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hypoglycaemia (n=119 measurements; median time prior to hypoglycaemic episode 104 
[range: 0–542] days), only 7/119 (6%) measurements were <48 mmol/mol (<6.5%), and the 
mean HbA1c concentration was 70 (SD: 19) mmol/mol (8.5% [SD: 1.7%]; Fig. 3).  
Healthcare resource utilisation 
Severe hypoglycaemic event-related resource utilisation 
Ninety-nine of 140 episodes of severe hypoglycaemia (71%) involved ambulance call-outs 
(Table 2), of which 83 required no onward emergency care. Sixteen call-outs led to A&E 
attendance, of which 5 led to non-elective inpatient admission. Ten episodes (7%) involved 
A&E visits without ambulance call-out or admission, 2 (1%) episodes involved other hospital 
interventions and 29 (21%) episodes were managed without immediate healthcare 
professional (HCP) intervention (Table 2). The mean cost of the early management of severe 
hypoglycaemia during the 2-year observation period was £240.52 per episode (Table 2). 
Ambulance call-out costs alone (£18,668) accounted for 55.4% of the total severe 
hypoglycaemia-related healthcare expenditure. 
Diabetes clinic consultations during the 2-year observation period 
During the 2-year observation period, participants attended a median of 5 (IQR: 2–7; range: 
0–58) diabetes clinic consultations (Table 3). Only 70/552 (13%) consultations were 
recorded as for hypoglycaemia follow-up (in 48 participants); of these, 10/70 (14%) did not 
follow a reported episode. The median time between episodes of severe hypoglycaemia and 
hypoglycaemia follow-up consultations (n=60) was 2 (range: 0–270) days, with 19/60 (32%) 
taking place on the same day (telephone consultations; Fig. 2).  
Adjustments to diabetes treatment 
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Overall, 119 HCP-recommended adjustments to diabetes treatment were recorded during 
the 2-year observation period (median per person 0 [range: 0–11]). The most commonly 
recorded reason for treatment changes was hypoglycaemic event (52/119 changes [44%]; 
Table 4). 
Timing of diabetes clinic visits and anti-diabetes medication adjustments in relation to 
severe hypoglycaemia  
For the sub-group of 72 episodes of severe hypoglycaemia with 3 months’ data available 
pre- and post-hypoglycaemia, 68 routine diabetes management and 41 hypoglycaemia 
follow-up consultations were recorded during the 6 month period; of these, 28/109 (26%) 
occurred during the 3 months before, 12/109 (11%) occurred on the same day (telephone 
consultations) and 69/109 (63%) occurred during the 3 months after the event. Forty 
diabetes treatment changes were recorded during this 6-month period; of these, 7/40 (18%) 
occurred during the 3-months before (median 0 [range: 0–3]; 4/7 changes were dose 
increases), 4/40 (10%) occurred on the same day (median per person 0 [range: 0–2]) and 
29/40 (73%) occurred during the 3 months after the episodes of severe hypoglycaemia. 
Forty-three percent of changes were dose reductions, all of which were recorded in the 3 
months following episodes of severe hypoglycaemia. 
Non-hypoglycaemia-related NHS resource utilisation 
Overall, 118 non-hypoglycaemia-related hospital attendances/admissions were recorded 
during the 2-year observation period, including 45 non-elective admissions (Figure S1).  
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Discussion 
Despite the association between intensive/tight glycaemic control and the increased risk of 
hypoglycaemia reported in the DCCT [1,4], the large majority of participants with self-
reported severe hypoglycaemia in our study had relatively poor glycaemic control. Two-
fifths of participants had more than one episode of severe hypoglycaemia during the 2-year 
observation period and almost three-quarters of all episodes involved an ambulance call-
out. Despite this, the frequency of diabetes clinic consultations and HbA1c assessments was 
lower than expected. Only 13% of consultations were documented as being for 
hypoglycaemia follow-up and at least 50% of participants did not have any HCP-
recommended changes to diabetes treatment documented during the 2-year observation 
period. 
The frequency of severe hypoglycaemia observed in our study is consistent with the 
prevalence estimated in people with Type 1 diabetes from real-world studies of between 0.7 
to 1.59 events per person per year, although considerably higher than the prevalence 
reported in clinical trials (0.15 to 0.5 episodes per person per year) [16]. We also found that 
71% of all hypoglycaemic episodes involved ambulance call-outs, which is greater than that 
reported in clinical trials [17]. This may reflect the practice of excluding people with Type 1 
diabetes at high risk of severe hypoglycaemia from clinical trials and differences in age and 
social support between our study population and clinical trial participants. 
The majority of participants in our study were treated with MDI insulin analogues, 
consistent with NICE recommendations for adults with Type 1 diabetes [8]. However, only 
11% of participants achieved an HbA1c at or below the NICE recommended target of 48 
mmol/mol (6.5%) at any point during the observation period. These data are consistent with 
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previous studies including DCCT [1], the National Diabetes Audit (NDA) [18], and results of a 
recent systematic review and meta-analysis [19], and suggest that the current NICE-
recommended HbA1c target remains aspirational and are unachievable for the majority of 
people. The relatively poor glycaemic control observed in our study is consistent with 
previous studies demonstrating that severe hypoglycaemia is associated with greater 
glucose variability and higher HbA1c levels [20,21]. Severe hypoglycaemia is also associated 
with longer duration of diabetes, impaired hypoglycaemia awareness , cognitive 
impairment, increased burden of comorbidities, β-blocker use and alcohol use [20–22], 
suggesting the high burden of comorbidities and concomitant medication use observed in 
our study may have contributed to the increased risk for developing severe hypoglycaemia. 
The ambulance service managed the majority of severe hypoglycaemic episodes without a 
requirement for A&E or inpatient admission, consistent with results of previous real-world 
studies [11–14,23,24]. This is likely to reflect UK recommendations for the development of 
pathways of care to reduce inpatient admissions in people with diabetes, including ‘see and 
treat’ policies for managing severe hypoglycaemia without admission, where appropriate 
[10]. Importantly, it is also recommended that collaborative pathways of care link 
hypoglycaemia-related ambulance attendances with enhanced diabetes education and 
medication review by patients’ usual diabetes service [10]. Therefore, considering NICE 
recommends review and HbA1c measurements every 3–6 months for people with 
uncomplicated Type 1 diabetes [8], the frequency of outpatient review for this high-risk 
cohort was low.  Although two-fifths of participants had more than one episode of severe 
hypoglycaemia, only 13% of all diabetes clinic visits were recorded as being for 
hypoglycaemia follow-up. Despite a higher frequency of diabetes clinic consultations for 
routine diabetes management or hypoglycaemia follow-up in the 3 months after an episode 
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than before, there is no indication in our study of a sustained increase in frequency of 
review following severe hypoglycaemia. Furthermore, no changes to diabetes treatment 
were recorded in >50% of our participants during the 2-year observation period. Therefore, 
despite considerable innovation in development of effective pathways for automatic 
ambulance service referral of people with hypoglycaemia to primary, community and 
secondary care services for early follow-up [12,14,25], our results may suggest that 
specialist diabetes services are clinically unresponsive to (or remain unaware of) severe 
hypoglycaemic episodes. However, since individuals routinely self-manage their insulin 
therapy to balance daily carbohydrate consumption and activity, it is possible that some 
participants were aware of the cause of hypoglycaemia and took action to avoid future 
occurrences without requiring healthcare advice. 
The rates of admissions for severe hypoglycaemia in individuals with Type 1 diabetes, after 
adjusting for population prevalence, has fallen in recent years; however, due to the 
increasing prevalence of diabetes, treatment of severe hypoglycaemia has important 
implications for healthcare resources [26]. Admissions for severe hypoglycaemia have been 
estimated to cost the NHS an average of £1034 per event [27]. Our study has estimated that 
the average cost associated with self-reported episodes of severe hypoglycaemia that are 
largely managed without hospital admission is £240.52, with the major financial burden 
being shouldered by the ambulance service. These results are broadly consistent with 
previous UK studies specifically evaluating severe hypoglycaemia requiring ambulance 
service attendance  [11,14,24]. However, the burden of severe hypoglycaemia is not only 
financial: there is also a significant effect on individuals in terms of reduced quality of life, 
reduced work productivity and poorer clinical outcomes [16]. Most importantly, it has been 
reported that 4.45% of people with Type 1 diabetes with severe hypoglycaemia requiring an 
18 
 
ambulance call-out died within 12 months of the last presentation, with a median age of 54 
years [13], and 5.2% of people hospitalised for severe hypoglycaemia died within 30 days in 
2010 [28]. In this context, the high level of ambulance service intervention but low levels of 
hypoglycaemia follow-up, therapy change and specialist intervention observed in our study 
suggest, firstly, a missed opportunity to reduce future risk of hypoglycaemia and, secondly, 
a need for greater integration of care pathways for people with Type 1 diabetes and severe 
hypoglycaemia. The majority of episodes of severe hypoglycaemia evaluated in our study 
required ambulance service attendance, supporting the prominent role of ambulance 
services in delivering deliver, or facilitating access to, healthcare advice and support at a 
time when people (and carers) may be most receptive [11,12,14,23,24]. However, 21% of 
episodes in our study did not involve immediate HCP intervention, suggesting that directly 
questioning people with Type 1 diabetes about episodes of severe hypoglycaemia using 
standardised clinical scales at every diabetes clinic visit may help to improve reporting, 
evaluation and intervention for all patients experiencing severe hypoglycaemia.  
Strengths and weaknesses of the study 
Our cohort may not be representative of the wider population of people with Type 1 
diabetes suffering severe hypoglycaemia for a number of reasons. The majority of 
participants included in this study were older than 55 years, broadly consistent with 
previous observational studies [13,14,24] and suggesting that older people with Type 1 
diabetes are more prone to episodes of severe hypoglycaemia [29]. However, younger 
people with Type 1 diabetes (<40 years) are reported to be less likely to attend diabetes 
appointments [18]  and are less likely to self-report severe hypoglycaemia due to the risk of 
disqualification from driving [30]. Therefore, younger people may be under-represented in 
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our cohort and those of previous observational studies. As with all retrospective studies, the 
interpretation of our results is reliant on the quality of the information available in 
participants’ medical records. Therefore, as participant identification relied on self-reported 
severe hypoglycaemia, those episodes requiring no interaction with NHS services could not 
be verified and are likely to have been under-reported (because of unwillingness or recall 
bias), leading to an overestimation of the proportion of episodes requiring ambulance call-
out. We also cannot exclude the possibility that HCP recall bias influenced participant 
identification and selection, although a variety of methods were employed to identify 
eligible individuals. Furthermore, the limited number of consultations for hypoglycaemia 
follow-up may reflect a lack of detailed recording of discussions about hypoglycaemia during 
consultations, especially in instances where the cause was known and considered unlikely to 
recur. The study included patients reporting severe hypoglycaemia at any point within 
previous 2 years, therefore, patients had a variable period of follow-up before and after the 
event which may have limited the time available to observe changes in diabetes 
management. Furthermore, since many patient pathways for linking hypoglycaemia-related 
ambulance attendances with diabetes services have been implemented since 2014, it is 
possible that patients requiring ambulance attendance earlier during the study observation 
period may have been less likely to have been referred to diabetes services than those 
towards the end of the observation period. 
One strength of this study is that participants were recruited from 10 hospitals 
geographically distributed across England and Wales, so the results may be generalizable to 
the UK population. In addition, we evaluated emergency and non-emergency hospital 
resource utilisation, including all diabetes centre consultations, HbA1c evaluations and HCP-
recommended changes to diabetes therapy. This has enabled an evaluation of the temporal 
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relationship between severe hypoglycaemia and secondary care interventions. However, we 
were not able to evaluate costs associated with post-hypoglycaemia consultations in 
primary care; this is worthy of further study.  
Conclusions 
The results of our study suggest three gaps in the diabetes care pathway warranting further 
evaluation: (1) lack of a consistent mechanism for reporting by paramedics to primary care 
and subsequent referral of individuals to specialist diabetes services, (2) lack of a consistent 
approach to early follow-up of self-reported episodes of severe hypoglycaemia by specialist 
diabetes services, and (3) low levels of HCP-recommended therapy change and ongoing 
specialist review following self-reported episodes of severe hypoglycaemia.  
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Table 1. Participant demographic and clinical characteristics at data collection 
BMI, kg/m2 (mean [SD]; n=79) 26.8 [4.7] 
Selected comorbidities, n (%) 
Retinopathy 
Hypertension 
Cardiovascular disease 
Nerve damage 
Kidney disease 
Diabetic foot ulcers 
 
53 (62%) 
41 (48%) 
25 (29%) 
21 (25%) 
14 (16%) 
8 (9%) 
HbA1c, mmol/mol; %, mean (SD) 69 (17); 8.4% (1.6%) 
Insulin therapy, n (%) 
MDI 
CSII 
Other 
 
70 (82.4%) 
5 (5.9%) 
10 (11.8%) 
Concomitant non-diabetes medication, n (%) 
Statins 
Non-β-blocker antihypertensives 
β-blockers 
Antiplatelets 
 
57 (67%) 
40 (47%) 
13 (15%) 
8 (9%) 
BMI: body mass index; CSII: continuous subcutaneous infusion; MDI: multiple daily injection 
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Table 2. NHS resource utilisation costs associated with severe hypoglycaemia 
Resource(s) used n 
Mean cost per 
episodea 
Total cost of 
episodes 
Total resource pathway for ambulance call-outs 
Ambulance call-out (no conveyance) 83 £180.00 £14,940.00 
Ambulance call-out and A&E attendance 11 £359.51 £3,954.56 
Ambulance call-out, A&E attendance 
and non-elective inpatient admission 
5 £2,575.82b £12,879.10 
A&E attendance without ambulance 10 £126.51 £1,265.06 
Other healthcare resource use 2 £316.75c £633.49 
No qualified healthcare intervention 29 £0 £0 
All episodes 140 £240.52 £33,672.21 
Total for ambulance call-outs alone 99 £188.57d £18,668.00 
A&E: Accident and Emergency. aMean cost based on number of episodes for each type of resource(s) 
used, based on NHS reference costs [16]; any differences between mean cost per episode and total 
cost of episodes are due to rounding. bBased on the weighted average daily non-elective inpatient 
costs; ccosted as appropriate to type; dbased on costs for ambulance attendances only (£180) or 
ambulance attendance with conveyance to hospital (£233), as appropriate. 
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Table 3. Diabetes clinic consultations recorded during the 2-year observation period 
Reason for consultations Number of consultations (% of n=552) 
Routine diabetes management 280 (51%) 
Foot clinic 103 (19%) 
Hypoglycaemia follow-up 70 (13%) 
Ophthalmology/eye clinics 35 (6%) 
Medication change 12 (2%) 
Nephrology 10 (2%) 
Pump clinic 4 (1%) 
Vascular clinic 3 (1%) 
Other 35 (6%) 
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Table 4. Reasons for changes to diabetes treatment during the 2-year observation period 
Reason for change 
Changes during observation period (% of 
n=119) 
Hypoglycaemic event 52 (44%) 
Adverse event 2 (2%) 
Personal choice 13 (11%) 
Hyperglycaemiaa 8 (7%) 
Clinician/nurse advice 4 (3%) 
Other 9 (8%) 
Not known 31 (26%) 
aIncludes ‘High blood glucose on waking’ reported in 3/8 participants 
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Figure legends 
 
Figure 1. Participant characteristics at data collection (n=85). Panel (a): age and sex 
distributions. Panel (b): distribution of duration of diabetes. 
 
Figure 2. Severe hypoglycaemia events and associated emergency resource utilisation 
during the 2-year observation period. Panel (a): severe hypoglycaemia events/person (total 
of 140 events in 85 participants). Panel (b): time between episodes of severe hypoglycaemia 
and hypoglycaemia follow-up consultations (n=60 hypoglycaemia follow-up consultations 
documented following a severe hypoglycaemic event).  
 
Figure 3. Distribution of HbA1c measured most closely prior to the severe hypoglycaemic 
events. (HbA1c measured prior to n=119 severe hypoglycaemic events)  
 
 
 
